Curium to acquire Lantheus Holdings in deal worth up to $8.0 billion
A radiopharmaceutical company, one that develops drugs using radioactive compounds to help clinicians detect and treat disease, is changing hands in a deal valued at up to $8.0 billion. Cur
NDNewsDialy Desk2 MIN READLNTH
SOURCE
Keep reading
More from the desk.
Tomorrow · 06:00
Start tomorrow already ahead.
Five stories, a two-minute read, zero noise — the world before your first coffee.